Cargando…
Assessment of Vaccine Hesitancy to a COVID-19 Vaccine in Cameroonian Adults and Its Global Implication
Since the outbreak of COVID-19 in December 2019, no global consensus treatment has been developed and generally accepted for the disease. However, eradicating the disease will require a safe and efficacious vaccine. In order to prepare for the eventual development of a safe and efficacious COVID-19...
Autores principales: | Dinga, Jerome Nyhalah, Sinda, Leontine Kouemou, Titanji, Vincent P. K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922050/ https://www.ncbi.nlm.nih.gov/pubmed/33669659 http://dx.doi.org/10.3390/vaccines9020175 |
Ejemplares similares
-
Factors Driving COVID-19 Vaccine Hesitancy in Cameroon and Their Implications for Africa: A Comparison of Two Cross-Sectional Studies Conducted 19 Months Apart in 2020 and 2022
por: Dinga, Jerome Nyhalah, et al.
Publicado: (2022) -
Commentary on COVID-19 Vaccine Hesitancy in sub-Saharan Africa
por: Kabakama, Severin, et al.
Publicado: (2022) -
TpUB05, a Homologue of the Immunodominant Plasmodium falciparum Protein UB05, Is a Marker of Protective Immune Responses in Cattle Experimentally Vaccinated against East Coast Fever
por: Dinga, Jerome Nyhalah, et al.
Publicado: (2015) -
COVID-19 perceptions and vaccine hesitancy: Acceptance, attitude, and barriers among Cameroonians
por: Ajonina-Ekoti, Irene U., et al.
Publicado: (2022) -
Analysis of the Role of TpUB05 Antigen from Theileria parva in Immune Responses to Malaria in Humans Compared to Its Homologue in Plasmodium falciparum the UB05 Antigen
por: Dinga, Jerome Nyhalah, et al.
Publicado: (2020)